3Dタンパク質構造解析市場：コンポーネント、手法、エンドユーザー別 - 2024年～2030年の世界予測

3Dタンパク質構造解析市場規模は2023年に12億5,000万米ドルと推計され、2024年には13億8,000万米ドルに達し、CAGR 10.04%で2030年には24億5,000万米ドルに達すると予測されます。

3Dタンパク質構造解析の世界市場

3Dタンパク質構造解析市場は、タンパク質分子内の原子の3次元配置を決定するために使用される製品、サービス、ソリューションの範囲で構成されます。これらのソリューションは、生化学、分子生物学、薬理学、バイオテクノロジー分野の研究者や専門家が、タンパク質の機能、相互作用、生物学的プロセス内の全体的なメカニズムを理解するのに役立ちます。3Dタンパク質構造解析の主なアプリケーションには、創薬や薬剤設計、タンパク質機能解析、疾病メカニズムの解明などがあります。この分野に革命をもたらしている主なエンドユーザーには、学術研究機関、製薬会社、バイオテクノロジー企業、CRO（医薬品開発業務受託機関）などが含まれます。研究開発への投資の増加や、慢性疾患の蔓延による新薬開発需要の急増により、市場規模は拡大しています。計算能力とバイオインフォマティクス・ツールの進歩は、市場のすそ野をさらに広げています。成長の促進要因としては、タンパク質構造解析手法の技術的進歩、バイオ医薬品会社による研究開発投資の増加、学術機関と民間企業間の学際的共同研究の増加などが挙げられます。さらに、個別化医療と構造生物学への注目の高まりは、市場を前進させる上で重要な役割を果たしています。3Dタンパク質構造解析における新たなビジネスチャンスは、タンパク質の構造予測と解析における人工知能と機械学習の採用から生まれます。さらに、新興諸国の未開拓市場への進出や、COVID-19のような新興疾患の研究における3Dタンパク質モデルの応用は、潜在的な成長の道を提供します。

地域別の洞察

米国は、バイオテクノロジー研究のための強力なインフラ、官民双方からの多額の投資、新興企業や既存企業の活気あるエコシステムなどの恩恵を受けて、3Dタンパク質構造解析市場の最前線に立っています。著名な製薬会社や有名な学術・研究機関が存在することで、技術革新と顧客購買が促進されています。このことは、世界最高水準にある特許の取得件数にも反映されています。EU諸国には確立された製薬産業と高度な研究機関があり、これが3Dタンパク質構造解析の需要を牽引しています。EUの規制の枠組みやHorizon Europeのような資金提供の仕組みは、タンパク質分析における共同研究や技術革新を奨励しています。Innovative Medicines Initiative（IMI）のようなイニシアチブは、主要な業界関係者間のパートナーシップを促進し、地域全体の投資と新技術の採用を促進します。MEA地域では、市場情勢は多様です。中東の一部の国々は先進的なヘルスケアシステムを持ち、調査への投資も拡大しているが、アフリカ諸国の多くはまだ未開拓の可能性を秘めた急成長市場です。国際機関からの資金提供の増加や、技術移転のための先進国との連携が、これらの地域の成長を促進する可能性があります。アジア太平洋地域は、世界のタンパク質構造解析市場の中で急速に成長している地域です。中国は急成長するバイオテクノロジー部門と基礎研究への政府投資により、重要なプレーヤーとして位置づけられています。日本は先駆的なタンパク質研究とハイテク機器技術で、依然として技術集約型の市場であり、インドは拡大するバイオ医薬品産業と改善する研究インフラで魅力的な市場として浮上しています。経済的背景は様々ですが、これらの国々はヘルスケアと医薬品開発におけるイノベーションを追求するという点で共通しており、3Dタンパク質分析ソリューションに対する需要の高まりにつながっています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、3Dタンパク質構造解析市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、3Dタンパク質構造解析市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-3Dタンパク質構造解析市場の市場規模および予測は？

2-3Dタンパク質構造解析市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-3Dタンパク質構造解析市場における技術動向と規制の枠組みは？

4-3Dタンパク質構造解析市場における主要ベンダーの市場シェアは？

5-3Dタンパク質構造解析市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 病気の進行におけるタンパク質の重要性についての科学的認識の高まり
    • 医薬品の研究開発への投資の増加
  • 抑制要因
    • 熟練した人材の不足と3Dタンパク質構造解析の実行の困難
  • 機会
    • 3Dタンパク質構造解析の機器の技術進歩
    • 3Dタンパク質構造解析の自動化とバイオインフォマティクスツールの使用に焦点を当てる
  • 課題
    • タンパク質の構造と相互作用を正確に予測する際の技術的な限界
• 市場セグメンテーション分析
  • コンポーネント：ソフトウェアは、その使いやすさ、データの正確さ、強力な視覚化ツール、継続的なサポートとアップデートで高く評価されています。
  • 技術：クライオ電子顕微鏡は、動的プロセスと一時的なタンパク質構造の研究に推奨される選択肢です。
  • エンドユーザー：3Dタンパク質構造解析は、製薬会社やバイオテクノロジー会社で、科学的進歩を市場性のある治療法に迅速に変換するために非常に重要に使用されます。
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 3Dタンパク質構造解析市場：コンポーネント別

• 消耗品
• 機器
• ソフトウェア

第7章 3Dタンパク質構造解析市場：技術別

• クライオ電子顕微鏡
• NMR分光法
• X線結晶構造解析

第8章 3Dタンパク質構造解析市場：エンドユーザー別

• 学術機関・政府機関
• 受託研究機関
• 製薬・バイオテクノロジー企業

第9章 南北アメリカの3Dタンパク質構造解析市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の3Dタンパク質構造解析市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの3Dタンパク質構造解析市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析
  • 合併・買収
  • 契約、コラボレーション、パートナーシップ

第13章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • Agilent Technologies, Inc.
  • Anton Paar GmbH
  • Arinax Scientific Instrumentation
  • Bio-Prodict
  • Bruker Corporation
  • Cambridge Isotope Laboratories, Inc.
  • CD ComputaBio
  • Charles River Laboratories, Inc.
  • Corning Incorporated
  • Creative Proteomics
  • Dassault Systemes SE
  • Discngine SAS
  • DNASTAR
  • Fujifilm Holdings Corporation
  • Greiner Bio-One International GmbH
  • Hampton Research Corporation
  • Jena Bioscience GmbH
  • JEOL Ltd.
  • Malvern Panalytical Ltd.
  • Merck KGaA
  • MiTeGen, LLC
  • Molecular Dimensions
  • NanoImaging Services
  • Promega Corporation
  • Rigaku Corporation
  • Saromics Biostructures AB
  • Schrodinger, Inc.
  • Sygnature Discovery Ltd.
  • Thermo Fisher Scientific Inc.
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. 3D PROTEIN STRUCTURE ANALYSIS MARKET RESEARCH PROCESS
• FIGURE 2. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. 3D PROTEIN STRUCTURE ANALYSIS MARKET DYNAMICS
• FIGURE 7. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 8. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 10. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. 3D PROTEIN STRUCTURE ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 22. 3D PROTEIN STRUCTURE ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. 3D PROTEIN STRUCTURE ANALYSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 6. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 10. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY CRYO ELECTRON MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY NMR SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 14. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 28. CANADA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. CHINA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 45. CHINA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. INDIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 48. INDIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ITALY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 100. ITALY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. POLAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 112. POLAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. QATAR 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 115. QATAR 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM 3D PROTEIN STRUCTURE ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. 3D PROTEIN STRUCTURE ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 145. 3D PROTEIN STRUCTURE ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. 3D PROTEIN STRUCTURE ANALYSIS MARKET LICENSE & PRICING

[186 Pages Report] The 3D Protein Structure Analysis Market size was estimated at USD 1.25 billion in 2023 and expected to reach USD 1.38 billion in 2024, at a CAGR 10.04% to reach USD 2.45 billion by 2030.

Global 3D Protein Structure Analysis Market

The market for 3D protein structure analysis comprises the range of products, services, and solutions used in determining the three-dimensional arrangement of atoms within a protein molecule. These solutions aid researchers and professionals in the field of biochemistry, molecular biology, pharmacology, and biotechnology to comprehend protein function, interaction, and the overall mechanism within biological processes. The primary applications of 3D protein structure analysis include drug discovery and design, protein function analysis, and understanding disease mechanisms. Key end-users revolutionizing the field encompass academic research institutions, pharmaceutical and biotechnological companies, and contract research organizations (CROs). Market scope expands with increased investments in research and development activities and a surge in demand for new drug discovery fueled by the growing prevalence of chronic diseases. The advancement of computational power and bioinformatics tools has further broadened the scope of the market. Growth drivers include technological advancements in protein structure analysis methods, rising investment in research and development by biopharmaceutical companies, and the growing number of interdisciplinary collaborations between academic institutions and the private sector. Moreover, the increased focus on personalized medicine and structural biology plays a crucial role in propelling the market forward. New opportunities in the 3D protein structure analysis stem from the adoption of artificial intelligence and machine learning in protein structure prediction and analysis. Additionally, the expansion into untapped markets in developing countries and the application of 3D protein models in the study of emerging diseases like COVID-19 offer potential growth avenues.

Regional Insights

The United States stands at the forefront of the 3D protein structure analysis market, benefiting from a strong infrastructure for biotechnological research, substantial investment from both public and private sectors, and a vibrant ecosystem of startups and established corporations. The presence of prominent pharmaceutical companies, as well as renowned academic and research institutions, fuels innovation and customer purchasing. This is reflected in the volume of patents issued, which is among the highest globally. EU countries have well-established pharmaceutical industries and sophisticated research institutions that drive the demand for 3D protein structure analysis. The EU's regulatory framework and funding mechanisms such as Horizon Europe encourage collaborative research and innovation in protein analysis. Initiatives such as the Innovative Medicines Initiative (IMI) foster partnerships between key industry players, enhancing investment and adoption of new technologies across the region. The MEA region shows a varied landscape in the 3D protein structure analysis market. While certain countries in the Middle East have advanced healthcare systems with growing investment in research, many African nations are still burgeoning markets with untapped potential. Increased funding from international bodies and collaboration with developed nations for technology transfer can drive growth in these regions. The Asia Pacific region represents a rapidly growing section of the global protein structure analysis market. China's fast-growing biotech sector and heavy government investment in basic research have positioned it as a significant player. Japan remains a technology-intense market with pioneering protein research and high-tech instrumentation techniques, while India is emerging as an attractive market with its expanding biopharmaceutical industry and improving research infrastructure. Despite diverse economic backgrounds, these countries have a common pursuit towards innovation in healthcare and drug development, leading to increased demand for 3D protein analysis solutions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the 3D Protein Structure Analysis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Protein Structure Analysis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the 3D Protein Structure Analysis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Anton Paar GmbH, Arinax Scientific Instrumentation, Bio-Prodict, Bruker Corporation, Cambridge Isotope Laboratories, Inc., CD ComputaBio, Charles River Laboratories, Inc., Corning Incorporated, Creative Proteomics, Dassault Systemes SE, Discngine SAS, DNASTAR, Fujifilm Holdings Corporation, Greiner Bio-One International GmbH, Hampton Research Corporation, Jena Bioscience GmbH, JEOL Ltd., Malvern Panalytical Ltd., Merck KGaA, MiTeGen, LLC, Molecular Dimensions, NanoImaging Services, Promega Corporation, Rigaku Corporation, Saromics Biostructures AB, Schrodinger, Inc., Sygnature Discovery Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the 3D Protein Structure Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Component
  • Consumable
  • Instrument
  • Software
• Technique
  • Cryo Electron Microscopy
  • NMR spectroscopy
  • X-ray Crystallography
• End-User
  • Academic & Government Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the 3D Protein Structure Analysis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Protein Structure Analysis Market?

3. What are the technology trends and regulatory frameworks in the 3D Protein Structure Analysis Market?

4. What is the market share of the leading vendors in the 3D Protein Structure Analysis Market?

5. Which modes and strategic moves are suitable for entering the 3D Protein Structure Analysis Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. 3D Protein Structure Analysis Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing scientific awareness about the importance of proteins in disease progression
    • 5.1.1.2. Rise in investment for research and development of drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled personnel and difficulty in performing 3d protein structure analysis
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in equipment for 3D protein structure analysis
    • 5.1.3.2. Focus on automation and use of bioinformatics tools in 3D protein structure analysis
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations in accurately predicting protein structure and interactions
• 5.2. Market Segmentation Analysis
  • 5.2.1. Components: Softwares are highly valued for its user-friendliness, data accuracy, powerful visualization tools, and ongoing support and updates
  • 5.2.2. Technology: Cryo-Electron Microscopy is a preferred choice for studying dynamic processes and transient protein structures
  • 5.2.3. End-User: 3D protein structure analysis used crucially in pharmaceutical and biotechnology companies for a swift translation of scientific breakthroughs into marketable therapies
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. 3D Protein Structure Analysis Market, by Component

• 6.1. Introduction
• 6.2. Consumable
• 6.3. Instrument
• 6.4. Software

7. 3D Protein Structure Analysis Market, by Technique

• 7.1. Introduction
• 7.2. Cryo Electron Microscopy
• 7.3. NMR spectroscopy
• 7.4. X-ray Crystallography

8. 3D Protein Structure Analysis Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Government Institutes
• 8.3. Contract Research Organizations
• 8.4. Pharmaceutical & Biotechnology Companies

9. Americas 3D Protein Structure Analysis Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific 3D Protein Structure Analysis Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa 3D Protein Structure Analysis Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player
  • 12.3.1. Merger & Acquisition
    • 12.3.1.1. Thermo Fisher to Acquire Olink for USD 3.1 Billion, Expanding Proteomics Presence
    • 12.3.1.2. Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development
  • 12.3.2. Agreement, Collaboration, & Partnership
    • 12.3.2.1. GenNext Technologies Announces Partnership with Emery Pharma on Full-Solution Biopharmaceutical Protein Footprinting Services

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. Agilent Technologies, Inc.
  • 13.1.2. Anton Paar GmbH
  • 13.1.3. Arinax Scientific Instrumentation
  • 13.1.4. Bio-Prodict
  • 13.1.5. Bruker Corporation
  • 13.1.6. Cambridge Isotope Laboratories, Inc.
  • 13.1.7. CD ComputaBio
  • 13.1.8. Charles River Laboratories, Inc.
  • 13.1.9. Corning Incorporated
  • 13.1.10. Creative Proteomics
  • 13.1.11. Dassault Systemes SE
  • 13.1.12. Discngine SAS
  • 13.1.13. DNASTAR
  • 13.1.14. Fujifilm Holdings Corporation
  • 13.1.15. Greiner Bio-One International GmbH
  • 13.1.16. Hampton Research Corporation
  • 13.1.17. Jena Bioscience GmbH
  • 13.1.18. JEOL Ltd.
  • 13.1.19. Malvern Panalytical Ltd.
  • 13.1.20. Merck KGaA
  • 13.1.21. MiTeGen, LLC
  • 13.1.22. Molecular Dimensions
  • 13.1.23. NanoImaging Services
  • 13.1.24. Promega Corporation
  • 13.1.25. Rigaku Corporation
  • 13.1.26. Saromics Biostructures AB
  • 13.1.27. Schrodinger, Inc.
  • 13.1.28. Sygnature Discovery Ltd.
  • 13.1.29. Thermo Fisher Scientific Inc.
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing